Design and rationale for the Myocardial Stem Cell Administration After Acute Myocardial Infarction (MYSTAR) Study: A multicenter, prospective, randomized, single-blind trial comparing early and late intracoronary or combined (percutaneous intramyocardial and intracoronary) administration of nonselected autologous bone marrow cells to patients after acute myocardial infarction

✍ Scribed by Noémi Nyolczas; Mariann Gyöngyösi; Gilbert Beran; Markus Dettke; Senta Graf; Heinz Sochor; Günther Christ; István Édes; László Balogh; Korff T. Krause; Kai Jaquet; Karl-Heinz Kuck; Imre Benedek; Theodora Hintea; Róbert Kiss; István Préda; Vladimir Kotevski; Hristo Pejkov; Darius Dudek; Grzegorz Heba; Christer Sylven; Silvia Charwat; Ronaldo Jacob; Gerald Maurer; Irene Lang; Dietmar Glogar

• Book ID: 116190772
• Publisher: Elsevier Science
• Year: 2007
• Tongue: English
• Weight: 244 KB
• Volume: 153
• Category: Article
• ISSN: 1097-6744
• DOI: 10.1016/j.ahj.2006.10.027